These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33706807)

  • 1. The cost-effectiveness of government actions to reduce sodium intake through salt substitutes in Vietnam.
    Taylor C; Hoek AC; Deltetto I; Peacock A; Ha DTP; Sieburg M; Hoang D; Trieu K; Cobb LK; Jan S; Webster J
    Arch Public Health; 2021 Mar; 79(1):32. PubMed ID: 33706807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The health gains and cost savings of dietary salt reduction interventions, with equity and age distributional aspects.
    Nghiem N; Blakely T; Cobiac LJ; Cleghorn CL; Wilson N
    BMC Public Health; 2016 May; 16():423. PubMed ID: 27216490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health Impact and Cost-Effectiveness of Achieving the National Salt and Sugar Reduction Initiative Voluntary Sugar Reduction Targets in the United States: A Microsimulation Study.
    Shangguan S; Mozaffarian D; Sy S; Lee Y; Liu J; Wilde PE; Sharkey AL; Dowling EA; Marklund M; Abrahams-Gessel S; Gaziano TA; Micha R
    Circulation; 2021 Oct; 144(17):1362-1376. PubMed ID: 34445886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing Health Research Impact through a Systemic Multi-Sectoral Approach: A Protocol for Introducing Reduced-Sodium Salts and Salty Condiments in Vietnam.
    Rosewarne E; Hoek AC; Palu A; Trieu K; Taylor C; Ha DTP; Sieburg M; Ide N; Buse K; Webster J
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling health gains and cost savings for ten dietary salt reduction targets.
    Wilson N; Nghiem N; Eyles H; Mhurchu CN; Shields E; Cobiac LJ; Cleghorn CL; Blakely T
    Nutr J; 2016 Apr; 15():44. PubMed ID: 27118548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of a Household Salt Substitution Intervention: Findings From 20 995 Participants of the Salt Substitute and Stroke Study.
    Li KC; Huang L; Tian M; Di Tanna GL; Yu J; Zhang X; Yin X; Liu Y; Hao Z; Zhou B; Feng X; Li Z; Zhang J; Sun J; Zhang Y; Zhao Y; Zhang R; Yu Y; Li N; Yan LL; Labarthe DR; Elliott P; Wu Y; Neal B; Lung T; Si L
    Circulation; 2022 May; 145(20):1534-1541. PubMed ID: 35311346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness Analysis.
    Collins B; Kypridemos C; Pearson-Stuttard J; Huang Y; Bandosz P; Wilde P; Kersh R; Capewell S; Mozaffarian D; Whitsel LP; Micha R; O'Flaherty M;
    Milbank Q; 2019 Sep; 97(3):858-880. PubMed ID: 31332837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis.
    Smith-Spangler CM; Juusola JL; Enns EA; Owens DK; Garber AM
    Ann Intern Med; 2010 Apr; 152(8):481-7, W170-3. PubMed ID: 20194225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Salt Reduction, Prevalence of Hypertension and Avoidable Burden of Stroke in Vietnam: Modelling the Health and Economic Impacts.
    Aminde LN; Phung HN; Phung D; Cobiac LJ; Veerman JL
    Front Public Health; 2021; 9():682975. PubMed ID: 34150712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health and economic impacts of eight different dietary salt reduction interventions.
    Nghiem N; Blakely T; Cobiac LJ; Pearson AL; Wilson N
    PLoS One; 2015; 10(4):e0123915. PubMed ID: 25910259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of population salt reduction interventions to prevent cardiovascular disease in Cameroon: mathematical modelling study.
    Aminde LN; Cobiac L; Veerman JL
    BMJ Open; 2020 Nov; 10(11):e041346. PubMed ID: 33234652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic evaluation of salt reduction policies to reduce coronary heart disease in England: a policy modeling study.
    Collins M; Mason H; O'Flaherty M; Guzman-Castillo M; Critchley J; Capewell S
    Value Health; 2014 Jul; 17(5):517-24. PubMed ID: 25128044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
    Marklund M; Zheng M; Veerman JL; Wu JHY
    PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of a government supported policy strategy to decrease sodium intake: global analysis across 183 nations.
    Webb M; Fahimi S; Singh GM; Khatibzadeh S; Micha R; Powles J; Mozaffarian D
    BMJ; 2017 Jan; 356():i6699. PubMed ID: 28073749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries.
    Mason H; Shoaibi A; Ghandour R; O'Flaherty M; Capewell S; Khatib R; Jabr S; Unal B; Sözmen K; Arfa C; Aissi W; Ben Romdhane H; Fouad F; Al-Ali R; Husseini A;
    PLoS One; 2014; 9(1):e84445. PubMed ID: 24409297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and cost-effectiveness of a school-based education program to reduce salt intake in children and their families in China.
    Li X; Jan S; Yan LL; Hayes A; Chu Y; Wang H; Feng X; Niu W; He FJ; Ma J; Han Y; MacGregor GA; Wu Y
    PLoS One; 2017; 12(9):e0183033. PubMed ID: 28902880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF.
    van Heesch MM; van Asselt AD; Evers JL; van der Hoeven MA; Dumoulin JC; van Beijsterveldt CE; Bonsel GJ; Dykgraaf RH; van Goudoever JB; Koopman-Esseboom C; Nelen WL; Steiner K; Tamminga P; Tonch N; Torrance HL; Dirksen CD
    Hum Reprod; 2016 Nov; 31(11):2527-2540. PubMed ID: 27907897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis.
    Pearson-Stuttard J; Kypridemos C; Collins B; Mozaffarian D; Huang Y; Bandosz P; Capewell S; Whitsel L; Wilde P; O'Flaherty M; Micha R
    PLoS Med; 2018 Apr; 15(4):e1002551. PubMed ID: 29634725
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.